Hemington Wealth Management Cytokinetics Inc Transaction History
Hemington Wealth Management
- $398 Million
- Q4 2024
A detailed history of Hemington Wealth Management transactions in Cytokinetics Inc stock. As of the latest transaction made, Hemington Wealth Management holds 33 shares of CYTK stock, worth $1,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33
Previous 44
25.0%
Holding current value
$1,686
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$750 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$609 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$550 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$403 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$315 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.81B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...